Global Cell Culture Market: Growing Demand for Artificial Organs to Pave Way for Market’s Growth

The vendor landscape in the global cell culture market includes players such as VWR International LLC, Thermo Fisher Scientific Inc., GE Healthcare, Lonza Group Ltd., Becton, Dickinson & Co., Sigma-Aldrich Co. LLC., Corning Life Sciences B.V., EMD Millipore, PromoCell GmbH, and Wheaton Industries Inc. According to a TMR analyst, mergers and acquisitions among the key players are expected to strengthen the market in the coming years. 

Download Free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=405

Cell Culture Consumables Register Higher Demand than Serums and Reagents

The market players are registering increased demand for cell culture across the medical research sector. Cell cultures are being increasingly applied across drug screening and monitoring, disease diagnosis, biologic manufacturing, IVF technology, cancer research, and stem cell research. Increased investments by private medical organizations and government organizations have supported the growth of the global cell culture market. TMR states that among the cell culture consumables, cell culture media register the highest demand compared to serums and reagents. This is due to the key importance of the nature of the culture medium to the health of the cells.

3D Cell Culture to Define Future of Global Cell Culture Market

The growing demand for biopharmaceuticals and artificial organs, coupled with the emerging trend towards serum-free, customized and specialty media solutions is the primary factor contributing towards the growth of the global cell culture market. The increasing focus on stem cell research would further expand the scope of the market in future. TMR recommends that the focus on backward integration to conduct in-house research and sustaining pricing pressures amid a weak global economic scenario will open up significant opportunities for the market players.

However, ethical concern over the usage of animal sources in cell culture is one of the major restraints in the growth of the market. The usage of transgenic plants and animals, and stringent process controls will also impede the growth of the market in the years to come. “3D cell culture has the potential to serve as the future growth opportunity for the market and in vitro analysis.” a TMR analyst predicts.

Asia Pacific to Register Highest Demand for Cell Culture

TMR predicts that among the key regions in the global cell culture market, Asia Pacific will register the fastest growth during the period between 2014 and 2022. “The improvement in economic conditions of the developing countries in the Asia Pacific region such as China and India is anticipated to support the market’s growth,” the analyst states. In 2013, North America was the leading region in the market.

Browse Research Insights: http://www.transparencymarketresearch.com/cell-culture-market.html

TMR finds that the various opportunities in the global cell culture market will propel the expansion of the market at a CAGR of 7.1% during the period from 2014 to 2022. This would lead to an increase in the valuation of the market from US$6.1 bn in 2013 to US$11.3 bn in 2022.

Increasing Research-driven Medical Treatment Practices Propelling Global Cell Culture Market

Cell culture is a process wherein eukaryotic or prokaryotic cells are produced outside their natural environment, in controlled laboratory conditions. Heavy research involved in developing the optimum environment for cells to survive in artificial surroundings has led cell culture to emerge as one of the key tools in cellular and molecular biology, carcinogenesis, and mutagenesis studies. Owing to this, the global cell culture market is poised to be worth US$11.3 bn by 2022, increasing from its 2013 valuation of US$6.1 bn at a CAGR of 7.10% therein.

Growing Medical Research for Treatment of Multiple Diseases Benefits Global Market

The medical research sector exhibits an exclusive demand for cell cultures, wherein studies pertaining to aging and metabolic cell processes, origination of mutations, and effect of new drugs on cells are some of the major research areas that are benefitting the cell culture market. Cancer detection, manufacture of biologics, and drug discovery are some of the other medical research areas that are triggering growth of this market. 

R&D initiatives taken by life sciences and biotechnology companies, and academic and industry collaborations for the advancement of cell culture apparatus and methodologies have been significantly favorable for the growth of the cell culture market. The use of cell and tissue cultures to study the cellular mechanisms and drug response for diseases such as Parkinson’s and Alzheimer’s has been notable for the development of the cell culture market.

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

Ethical Reasons Favor Cell Culture Methodologies sans Animal Components

The global cell culture market is divided on the basis of product type into two major segments, cell culture instruments and cell culture consumables. Cell culture consumables comprise the sera, media, and reagent segments. Out of these, it is the cell culture media segment that will be the fastest growing. The growing preference for animal-derived-component-free (ADCF) media, which ensures compliance with the ethical standards of medical research, is attributed to the phenomenal rise of this market segment.

By instrument, culture systems, pipetting systems, biosafety cabinets, incubators, roller bottle equipment, cryostorage equipment, and others are the segments of the cell culture market. Technological advancement in the design and function of cell culture instruments and increasing adoption of automated culture systems by manufacturers and researchers are promoting growth of the instruments product segment of the market. 

Outsourcing Practices Benefit Asia Pacific Cell Culture Market 

Apart from this, the global market for cell culture is divided into the regional segments of North America, Asia Pacific, Rest of the World (RoW), Europe, and Latin America. In 2013, North America stood as the largest regional market for cell cultures. Consistent research initiatives, which involve huge investments for the development of biologics and drugs, and the presence of top-notch biotechnology, pharmaceutical, and food and beverages companies are propelling the cell culture market in the region.

Asia Pacific is expected to be the fastest growing market for cell culture in the near future. Economic growth in China and India, in particular, has led to the development of modern research and manufacturing facilities, which is encouraging contract-based manufacturing and contract-based research outsourcing practices from the West.

In the Rest of the World and Latin America regions, increasing investments from both public and private agencies for life sciences research is driving the cell culture market. Improving healthcare infrastructure and governmental support for modern research practices are further aiding the growth of this market. 

Browse Full Global Cell Culture Market Report With Complete TOC @ http://www.transparencymarketresearch.com/cell-culture-market.html